21 CFR 870.4075

§ 870.4075 Endomyocardial biopsy device.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 870.4075, § 870.4075 Endomyocardial biopsy device, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89984
Permanent ID: ys:prov:89984@1
SHA-256: a0264896653150fbc7871c84f25ef1d280fd95feb76b1a3fe5d9aceda5c62cdb

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. An endomyocardial biopsy device is a device used in a catheterization procedure to remove samples of tissue from the inner wall of the heart. (b) Classification. Class II (performance standards).

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.